Genetic markers of bevacizumab-induced hypertension.

Abstract:

PURPOSE:There are currently no validated biomarkers predicting bevacizumab treatment outcome or toxicity. We combined biomarker data from six phase III trials of bevacizumab to assess whether genetic variation in vascular endothelial growth factor-A (VEGF-A) pathway or hypertension-related genes are associated with bevacizumab-induced hypertension. EXPERIMENTAL DESIGN:Germline DNA was available from 1,631 patients receiving bevacizumab-containing therapy for advanced solid tumors. Overall, 194 white patients had grade 1-4 bevacizumab-induced hypertension. In total, 236 single nucleotide polymorphisms (SNPs) located in VEGF-A, VEGF-A receptors (FLT1 and KDR), and other genes were selected using a SNP tagging approach and genotyped. A logistic regression on individual patient data was performed after adjustment for cancer type and five other covariates. RESULTS:Ten SNPs were associated with bevacizumab-induced hypertension (P ≤ 0.05), but none surpassed the threshold adjusted for multiple testing (P < 0.0002). The most significant VEGF-A pathway SNP was rs1680695 in EGLN3 [allelic odds ratio (OR) 1.50 [95 % confidence interval (Cl) 1.09-2.07], P = 0.012]. Two additional SNPs, rs4444903 in EGF and rs2305949 in KDR, were associated with hypertension (allelic OR 1.57 [95 % CI 1.17-2.11], P = 0.0025; allelic OR 0.62 [95 % CI 0.42-0.93], P = 0.020, respectively) and closely linked to nearby functional variants. Consistent with previous reports, rs11064560 in WNK1 was also associated with bevacizumab-induced hypertension (OR 1.41 [95 % CI 1.04-1.92], P = 0.028). CONCLUSIONS:The genes described in this large genetic analysis using pooled datasets warrant further functional investigation regarding their role in mediating bevacizumab-induced hypertension.

journal_name

Angiogenesis

journal_title

Angiogenesis

authors

Lambrechts D,Moisse M,Delmar P,Miles DW,Leighl N,Escudier B,Van Cutsem E,Bansal AT,Carmeliet P,Scherer SJ,de Haas S,Pallaud C

doi

10.1007/s10456-014-9424-7

subject

Has Abstract

pub_date

2014-07-01 00:00:00

pages

685-94

issue

3

eissn

0969-6970

issn

1573-7209

journal_volume

17

pub_type

杂志文章
  • Effects of topical administration of 12-methyl tetradecanoic acid (12-MTA) on the development of corneal angiogenesis.

    abstract::Corneal vascularisation is a potentially devastating occurrence that can cause blindness. Currently, treatments for this condition are limited. In these studies, we have investigated a novel inhibitor of angiogenesis, 12-methyl tetradecanoic acid (12-MTA), to treat corneal vascularisation in mouse models of corneal al...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-007-9063-3

    authors: Cole N,Hume EB,Jalbert I,Vijay AK,Krishnan R,Willcox MD

    更新日期:2007-01-01 00:00:00

  • Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress.

    abstract::Altered RNA processing is an underlying mechanism of amyotrophic lateral sclerosis (ALS). Missense mutations in a number of genes involved in RNA function and metabolisms are associated with ALS. Among these genes is angiogenin (ANG), the fifth member of the vertebrate-specific, secreted ribonuclease superfamily. ANG ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-012-9322-9

    authors: Li S,Sheng J,Hu JK,Yu W,Kishikawa H,Hu MG,Shima K,Wu D,Xu Z,Xin W,Sims KB,Landers JE,Brown RH Jr,Hu GF

    更新日期:2013-04-01 00:00:00

  • Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.

    abstract::Anti-VEGF (vascular endothelial growth factor) therapy with the monoclonal antibody bevacizumab can cause gastrointestinal (GI) perforations. In recent years it became apparent that GI perforations also occur during treatment with antiangiogenic tyrosine kinase inhibitors (TKIs). It is of clinical importance to consid...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-010-9197-6

    authors: Walraven M,Witteveen PO,Lolkema MP,van Hillegersberg R,Voest EE,Verheul HM

    更新日期:2011-05-01 00:00:00

  • Models and molecular mechanisms of blood vessel co-option by cancer cells.

    abstract::Cancer cells have diverse mechanisms for utilizing the vasculature; they can initiate the formation of new blood vessels from preexisting ones (sprouting angiogenesis) or they can form cohesive interactions with the abluminal surface of preexisting vasculature in the absence of sprouting (co-option). The later process...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-019-09684-y

    authors: Zhang Y,Wang S,Dudley AC

    更新日期:2020-02-01 00:00:00

  • Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression.

    abstract::The semaphorins and plexins comprise a family of cysteine-rich proteins implicated in control of nerve growth and development and regulation of the immune response. Our group and others have found that Semaphorin 4D (SEMA4D) and its receptor, Plexin-B1, play an important role in tumor-induced angiogenesis, with some n...

    journal_title:Angiogenesis

    pub_type: 杂志文章,收录出版

    doi:10.1007/s10456-012-9268-y

    authors: Zhou H,Binmadi NO,Yang YH,Proia P,Basile JR

    更新日期:2012-09-01 00:00:00

  • CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism.

    abstract::CM101, an anti-pathoangiogenic polysaccharide derived from group B streptococcus, has been shown to inhibit inflammatory angiogenesis and accelerate wound healing in a mouse model and minimize scarring/gliosis following spinal cord injury. To evaluate the in vivo effects of CM101 on cutaneous wound healing in the pig,...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1016752925761

    authors: Nanney LB,Wamil BD,Whitsitt J,Cardwell NL,Davidson JM,Yan HP,Hellerqvist CG

    更新日期:2001-01-01 00:00:00

  • Are antiangiogenics a good 'partner' for immunotherapy in ovarian cancer?

    abstract::Ovarian cancer (OC) is associated with poor survival because there are a limited number of effective therapies. Two processes key to OC progression, angiogenesis and immune evasion, act synergistically to promote tumor progression. Tumor-associated angiogenesis promotes immune evasion, and tumor-related immune respons...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-020-09734-w

    authors: García-Martínez E,Redondo A,Piulats JM,Rodríguez A,Casado A

    更新日期:2020-11-01 00:00:00

  • In vivo malignant phenotype of hst-1-transfected cells regulated by paracrine endothelial cell growth stimulation by HST-1.

    abstract::The hst-1 gene product, one of the fibroblast growth factor family proteins, has transforming and angiogenic activities. The BALB/c 3T3 cell line was transfected with an expression vector harboring human hst-1 cDNA and the malignant properties of two stably transfected clones, TC-1 and TC-2, were examined. The stimula...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1009288405970

    authors: Aonuma M,Murakami K,Hirotani K,Horiuchi T,Sakamoto H,Terada M,Tanaka NG

    更新日期:1998-01-01 00:00:00

  • Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis.

    abstract:OBJECTIVE:Dysregulation of the phosphatidylinositol-3-kinase (PI3K) signaling pathway is a hallmark of human cancer, occurring in a majority of tumors. Activation of this pathway is critical for transformation and also for the angiogenic switch, which is a key step for tumor progression. The objective of this study was...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-009-9154-4

    authors: Harfouche R,Basu S,Soni S,Hentschel DM,Mashelkar RA,Sengupta S

    更新日期:2009-01-01 00:00:00

  • New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12.

    abstract::Angiogenesis was postulated to be a critical prognostic factor and therapeutic focus for malignancy more than two decades ago. Recent studies indicate quantitative assessments of microvessel count to be an independent prognostic variable for disease-free and overall survival in a wide variety of tumors, and that angio...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/A:1018301031580

    authors: Masiero L,Figg WD,Kohn EC

    更新日期:1997-01-01 00:00:00

  • Multiple angiogenesis stimulators in a single malignancy: implications for anti-angiogenic tumour therapy.

    abstract::Anti-angiogenesis is likely to develop into a novel therapeutic approach for patients with solid malignancies. Most current clinical trials evaluate anti-angiogenic drugs aimed primarily against single angiogenesis stimulators. Here, we show that a single solid malignancy, i.e., a human embryonal rhabdomyosarcoma, pro...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1016045012466

    authors: Pavlakovic H,Havers W,Schweigerer L

    更新日期:2001-01-01 00:00:00

  • Visualization of endothelial cell cycle dynamics in mouse using the Flt-1/eGFP-anillin system.

    abstract::Endothelial cell proliferation is a key process during vascular growth but its kinetics could only be assessed in vitro or ex vivo so far. To enable the monitoring and quantification of cell cycle kinetics in vivo, we have generated transgenic mice expressing an eGFP-anillin construct under control of the endothelial-...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-018-9601-1

    authors: Herz K,Becker A,Shi C,Ema M,Takahashi S,Potente M,Hesse M,Fleischmann BK,Wenzel D

    更新日期:2018-05-01 00:00:00

  • Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer.

    abstract::Angiopoietin-like (ANGPTL) proteins are secreted proteins showing structural similarity to members of the angiopoietin family. Some ANGPTL proteins possess pleiotropic activities, being involved in cancer lipid, glucose energy metabolisms, and angiogenesis. ANGPTL7 is the less characterized member of the family whose ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-014-9435-4

    authors: Parri M,Pietrovito L,Grandi A,Campagnoli S,De Camilli E,Bianchini F,Marchiò S,Bussolino F,Jin B,Sarmientos P,Grandi G,Viale G,Pileri P,Chiarugi P,Grifantini R

    更新日期:2014-10-01 00:00:00

  • TM4SF1: a new vascular therapeutic target in cancer.

    abstract::Transmembrane-4 L-six family member-1 (TM4SF1) is a small plasma membrane glycoprotein that regulates cell motility and proliferation. TM4SF1 is an attractive cancer target because of its high expression in both tumor cells and on the vascular endothelial cells lining tumor blood vessels. We generated mouse monoclonal...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-014-9437-2

    authors: Lin CI,Merley A,Sciuto TE,Li D,Dvorak AM,Melero-Martin JM,Dvorak HF,Jaminet SC

    更新日期:2014-10-01 00:00:00

  • Revascularization after angiogenesis inhibition favors new sprouting over abandoned vessel reuse.

    abstract::Inhibiting pathologic angiogenesis can halt disease progression, but such inhibition may offer only a temporary benefit, followed by tissue revascularization after treatment stoppage. This revascularization, however, occurs by largely unknown phenotypic changes in pathologic vessels. To investigate the dynamics of ves...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-019-09679-9

    authors: Mukwaya A,Mirabelli P,Lennikov A,Thangavelu M,Ntzouni M,Jensen L,Peebo B,Lagali N

    更新日期:2019-11-01 00:00:00

  • DNA methylation regulates lineage-specifying genes in primary lymphatic and blood endothelial cells.

    abstract::During embryonic development, the lymphatic system emerges by transdifferentiation from the cardinal vein. Although lymphatic and blood vasculature share a close molecular and developmental relationship, they display distinct features and functions. However, even after terminal differentiation, transitions between blo...

    journal_title:Angiogenesis

    pub_type: 临床试验,杂志文章

    doi:10.1007/s10456-012-9264-2

    authors: Brönneke S,Brückner B,Peters N,Bosch TC,Stäb F,Wenck H,Hagemann S,Winnefeld M

    更新日期:2012-06-01 00:00:00

  • Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.

    abstract:BACKGROUND:In patients with resectable colorectal liver metastases (CRLM), distinct histopathological growth patterns (HGPs) develop at the interface between the tumour and surrounding tissue. The desmoplastic (d) HGP is characterised by angiogenesis and a peripheral fibrotic rim, whereas non-angiogenic HGPs co-opt end...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-019-09661-5

    authors: Galjart B,Nierop PMH,van der Stok EP,van den Braak RRJC,Höppener DJ,Daelemans S,Dirix LY,Verhoef C,Vermeulen PB,Grünhagen DJ

    更新日期:2019-05-01 00:00:00

  • Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development.

    abstract::Both vasculogenesis and angiogenesis occur during normal placental vascular development. Additionally, the placenta undergoes a process of vascular mimicry (pseudo-vasculogenesis) where the placental extravillous trophoblast (EVT) that invade the spiral arteries convert from an epithelial to an endothelial phenotype d...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-012-9317-6

    authors: Kaspi E,Guillet B,Piercecchi-Marti MD,Alfaidy N,Bretelle F,Bertaud-Foucault A,Stalin J,Rambeloson L,Lacroix O,Blot-Chabaud M,Dignat-George F,Bardin N

    更新日期:2013-04-01 00:00:00

  • Hanging-drop multicellular spheroids as a model of tumour angiogenesis.

    abstract::The establishment of a vascular network within tumours is a key step in the progression towards an aggressive, metastatic state, with poor prognosis. We have developed a novel in vitro model to specifically capture the interaction between endothelial cells and solid tumours. Micro-vascularised in vitro tumour construc...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-004-8911-7

    authors: Timmins NE,Dietmair S,Nielsen LK

    更新日期:2004-01-01 00:00:00

  • AutoTube: a novel software for the automated morphometric analysis of vascular networks in tissues.

    abstract::Due to their involvement in many physiologic and pathologic processes, there is a great interest in identifying new molecular pathways that mediate the formation and function of blood and lymphatic vessels. Vascular research increasingly involves the image-based analysis and quantification of vessel networks in tissue...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-018-9652-3

    authors: Montoya-Zegarra JA,Russo E,Runge P,Jadhav M,Willrodt AH,Stoma S,Nørrelykke SF,Detmar M,Halin C

    更新日期:2019-05-01 00:00:00

  • Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling.

    abstract::Vascular endothelial cells undergo many molecular changes during pathological processes such as inflammation and tumour development. Tumours such as malignant lymphomas affecting bone marrow are dependent on interactions with endothelial cells for (1) site-specific homing and (2) tumour-induced angiogenesis. Modificat...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-010-9162-4

    authors: Willhauck-Fleckenstein M,Moehler TM,Merling A,Pusunc S,Goldschmidt H,Schwartz-Albiez R

    更新日期:2010-03-01 00:00:00

  • PDGFRβ-P2A-CreERT2 mice: a genetic tool to target pericytes in angiogenesis.

    abstract::Pericytes are essential mural cells distinguished by their association with small caliber blood vessels and the presence of a basement membrane shared with endothelial cells. Pericyte interaction with the endothelium plays an important role in angiogenesis; however, very few tools are currently available that allow fo...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-017-9570-9

    authors: Cuervo H,Pereira B,Nadeem T,Lin M,Lee F,Kitajewski J,Lin CS

    更新日期:2017-11-01 00:00:00

  • Recombinant human prothrombin kringles have potent anti-angiogenic activities and inhibit Lewis lung carcinoma tumor growth and metastases.

    abstract::Prothrombin, a protein involved in blood coagulation, is a plasma glycoprotein composed of the Gla domain, two adjacent kringle domains, and a serine protease domain. Kringles are triple-disulfide-loop folding domains, which are found in several other blood proteins. In this study, we showed that recombinant human pro...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/a:1023835102832

    authors: Kim TH,Kim E,Yoon D,Kim J,Rhim TY,Kim SS

    更新日期:2002-01-01 00:00:00

  • The role of endoglin in post-ischemic revascularization.

    abstract::Following arterial occlusion, blood vessels respond by forming a new network of functional capillaries (angiogenesis), by reorganizing preexisting capillaries through the recruitment of smooth muscle cells to generate new arteries (arteriogenesis) and by growing and remodeling preexisting collateral arterioles into ph...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-016-9535-4

    authors: Núñez-Gómez E,Pericacho M,Ollauri-Ibáñez C,Bernabéu C,López-Novoa JM

    更新日期:2017-02-01 00:00:00

  • Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni).

    abstract::noni, the juice of the fruit from the Morinda citrifolia plant, has been used for centuries as a medicinal agent. We tested the effects of noni juice in a three-dimensional fibrin clot matrix model using human placental vein and human breast tumor explants as sources for angiogenic vessel development. Noni in concentr...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1023/B:AGEN.0000011800.04507.4b

    authors: Hornick CA,Myers A,Sadowska-Krowicka H,Anthony CT,Woltering EA

    更新日期:2003-01-01 00:00:00

  • Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.

    abstract::Inhibition of angiogenesis has become a major target in experimental cancer therapies. Vascular endothelial growth factor (VEGF) and its receptors are essential for breast cancer progression and relevant targets in experimental anti-angiogenesis. VEGF, produced by carcinoma cells, acts in a paracrine fashion on endoth...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-005-9010-0

    authors: Weigand M,Hantel P,Kreienberg R,Waltenberger J

    更新日期:2005-01-01 00:00:00

  • Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.

    abstract:BACKGROUND:Vascular endothelial growth factor (VEGF) that is secreted by tumor cells plays a key role in angiogenesis. Matrix metalloproteinase 9 (MMP-9) is produced by inflammatory cells, such as stromal granulocytes (PMN), remodels the extracellular matrix and is known to promote angiogenesis indirectly by interactin...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-011-9207-3

    authors: Bausch D,Pausch T,Krauss T,Hopt UT,Fernandez-del-Castillo C,Warshaw AL,Thayer SP,Keck T

    更新日期:2011-09-01 00:00:00

  • Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.

    abstract::Molecular imaging agents are extending the potential of noninvasive medical diagnosis from basic gross anatomical descriptions to complicated phenotypic characterizations based upon the recognition of unique cell-surface biochemical signatures. Although originally the purview of nuclear medicine, "molecular imaging" i...

    journal_title:Angiogenesis

    pub_type: 杂志文章,评审

    doi:10.1007/s10456-010-9166-0

    authors: Lanza GM,Winter PM,Caruthers SD,Hughes MS,Hu G,Schmieder AH,Wickline SA

    更新日期:2010-06-01 00:00:00

  • Capillary arterialization requires the bone-marrow-derived cell (BMC)-specific expression of chemokine (C-C motif) receptor-2, but BMCs do not transdifferentiate into microvascular smooth muscle.

    abstract::Chemokine (C-C motif) receptor-2 (CCR2) regulates arteriogenesis and angiogenesis, facilitating the MCP-1-dependent recruitment of growth factor-secreting bone marrow-derived cells (BMCs). Here, we tested the hypothesis that the BMC-specific expression of CCR2 is also required for new arteriole formation via capillary...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-009-9157-1

    authors: Nickerson MM,Burke CW,Meisner JK,Shuptrine CW,Song J,Price RJ

    更新日期:2009-01-01 00:00:00

  • Protein kinase D2 and heat shock protein 90 beta are required for BCL6-associated zinc finger protein mRNA stabilization induced by vascular endothelial growth factor-A.

    abstract::Vascular endothelial growth factor (VEGF) is a major angiogenic factor that activates pro-angiogenic molecules to generate new vessels. Recently, we identified a VEGF-A-induced pro-angiogenic gene, BCL-6 associated zinc finger protein (BAZF), in endothelial cells. BAZF interacts with CBF1, a transcriptional regulator ...

    journal_title:Angiogenesis

    pub_type: 杂志文章

    doi:10.1007/s10456-013-9345-x

    authors: Miwa D,Sakaue T,Inoue H,Takemori N,Kurokawa M,Fukuda S,Omi K,Goishi K,Higashiyama S

    更新日期:2013-07-01 00:00:00